Diabetes

  • How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
    Wendy O. Henderson, MD, Mary H. Parker, PharmD, FASHP, FCCP, BCPS, BCCP and Bryan C. Batch, MD, MHS
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 81-85; DOI: https://doi.org/10.3949/ccjm.88a.19135

    Hemoglobin A1c is the standard but is not perfect. Alternatives are available.

  • The role of SGLT-2 inhibitors in managing type 2 diabetes
    Yumiko Tsushima, MD, M. Cecilia Lansang, MD, MPH and Vinni Makin, MBBS, MD, FACE
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 47-58; DOI: https://doi.org/10.3949/ccjm.88a.20088

    These drugs improve glycemic control and offer cardiovascular and metabolic benefits.

  • SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
    Jonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEd
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190

    Randomized controlled trials of these new agents had positive outcomes.

  • Peripheral artery disease and unusual skin findings
    Aaron Andrew Heigaard Smith, MD, Erin Luxenberg, MD and Roberta Meyers, MD, MPH
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 605-612; DOI: https://doi.org/10.3949/ccjm.87a.19074

    A 68-year-old man was admitted because of worsening skin problems in his legs.

  • Familial hypercholesterolemia: Clarifications
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 320; DOI: https://doi.org/10.3949/ccjm.87c.06001

    Comments on xanthoma vs xanthelasmas, and goal LDL-C.

  • In Reply: Familial hypercholesterolemia: Clarifications
    Nishant P. Shah, MD,FACC, Haitham M. Ahmed, MD and W. H. Wilson Tang, MD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 320; DOI: https://doi.org/10.3949/ccjm.87c.06002

    The authors' response.

  • Aspirin for primary prevention of atherosclerotic cardiovascular events
    CME article
    Aldo L. Schenone, MD and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine May 2020, 87 (5) 300-311; DOI: https://doi.org/10.3949/ccjm.87a.19045

    A more limited role for aspirin as primary prevention in patients at intermediate risk, with diabetes, and the elderly.

  • Type of diabetes mellitus: Does it matter to the clinician?
    Byron J. Hoogwerf, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 100-108; DOI: https://doi.org/10.3949/ccjm.87a.19020

    Understanding the many faces of diabetes can make a difference in how clinicians select glucose-lowering therapy.

  • In reply: How should diabetic dyslipidemia be treated?
    Ting-I Lee, MD, PhD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01004
  • How should diabetic dyslipidemia be treated?
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01003

Pages